Press Releases

CutisPharma Appoints Steven Dinh as Chief Scientific Officer

Filling of Key Role Accelerates Company’s Efforts to Develop Drug Portfolio Toward NDA Filings and FDA Approvals

WILMINGTON, Mass. (August 1, 2016) – CutisPharma today announced the appointment of Steven Dinh, Sc.D., as Executive Vice President and Chief Scientific Officer. In this key role, Dinh will oversee the Company’s efforts to develop its pipeline of drugs […]